1-Azar S, Wong TE. Sickle Cell Disease: A Brief Update. Med Clin North Am. 2017; 101(2): 375-393.
2- Patrick TM, Alecia CN, Russell EW. Current Management of Sickle Cell Anemia Cold Spring HarbPerspect Med. 2013; 3(8): a011817.
3- Institut national de la statistique et des études économiques. Estimation de la population au 1 er janvier 2016 [https://www.insee.fr/fr/statistiques/1893198].
4-Thein SL. Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle CellDisease. Adv Exp Med Biol. 2017;1013:27-57.
5-Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. Am J Hematol. 2012; 87(8):795-803.
6-Habara A, Steinberg MH. Minireview: Genetic basis of heterogeneity and severity in sickle cell disease. ExpBiol Med (Maywood). 2016; 241(7):689-96
7-Flanagan JM, Frohlich DM, Howard TA, Schultz WH, Driscoll C, Nagasubramanian R, et al. Genetic predictors for stroke in children with sickle cell anemia. Blood. 2011;117:6681–6684.
8-Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, et al. Fetal hemoglobin in sickle cell anemia. Blood. 2011;118:19–27.
9-Ngo DA, Akinsheye I, Hankins JS. Fetal hemoglobin levels and hematologic characteristics of compound heterozygotes for HbS and deletional hereditary persistence of fetal hemoglobin. Br J Haematol. 2012;156(2):259-264.
10-Bhatnagar P, Purvis S, Barron-Casella E, DeBaun MR, Casella JF, Arking DE, et al. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients. J Hum Genet. 2011;56:316–23
11-Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 1997; 89(5):1787-92.
12-Aleluia MM, Fonseca TCC, Souza RQ, Neves FI, da Guarda CC, Santiago RP, et al. Comparative study of sickle cell anemia and hemoglobin SC disease: clinical characterization, laboratory biomarkers and genetic profiles. BMC Hematol. 2017 ;17:15.
13-Sickle-Cell Anemia: Haplotype | Learn Science at Scitable [. https://www.nature.com/scitable/topicpage/sickle-cell-anemia-a-look-at-global-8756219
14-Muszlak M, Pissard S, Badens C, Chamouine A, Maillard O, Thuret I, et al. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island. Hemoglobin. 2015;39(3):156-161.
15-Ndugwa C, Higgs D, Fisher C, Hambleton I, Mason K, Serjeant BE, et al. Homozygous sickle cell disease in Uganda and Jamaica a comparison of Bantu and Benin haplotypes. West Indian Med J. 2012; 61(7):684-691.
16-Carvalho-dos Santos BS, Dias-Elias DB, da Silva-Rocha LB, Cavalcante-Barbosa M, Pinheiro-Gonçalves Ret al. Impact of β(S)-globin haplotypes on oxidative stress in patients with sickle cell anemia in steady state. Arch Med Res. 2012; 43(7):536-540.
17-Joly P, Garnier N, Kebaili K, Renoux C, Dony A, Cheikh N, et al. G6PD deficiency and absence of α-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia. Eur J Haematol. 2016; 96(4):404-408.
18-Benkerrou M, Alberti C, Couque N, Haouari Z, Ba A, Missud F, et al. Impact of glucose-6phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study. Br J Haematol. 2013;163(5):646-654.
19-Diop S, Sene A, Cisse M, Toure AO, Sow O, Thiam D, et al. [Prevalence and morbidity of G6PD deficiency in sickle cell disease in the homozygote]. Dakar Méd. 2005;50(2):56-60.
20- Bouanga JC, Mouélé R, Préhu C, Wajcman H, Feingold J, Galactéros F. Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Congo. Hum Hered. 1998;48(4):192-197.
21-el-Hazmi MA, Warsy AS, Bahakim HH, al-Swailem A. Glucose-6-phosphate dehydrogenase deficiency and the sickle cell gene in Makkah, Saudi Arabia. J Trop Pediatr. 1994; 40(1):12-16.
22- Dowling MM, Quinn CT, Rogers ZR, Buchanan GR. Acute silent cerebral infarction in children with sickle cell anemia. Pediatric Blood and Cancer. 2010; 54(3):461–464
23- Belisário AR, Silva CM, Velloso-Rodrigues C, Viana MB. Genetic, laboratory and clinical risk factors in the development of overt ischemic stroke in children with sickle cell disease. HematolTransfus Cell Ther. 2018; 40(2):166–181.
24- Jordan LC, Casella JF, DeBaun MR. Prospects for primary stroke prevention in children with sickle cell anaemia. Br J Haematol. 2012;157(1):14–25.
25- Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, et al. Fetal hemoglobin in sickle cell anemia. Blood. 2011; 118(1):19-27.
26-Bauer DE, Orkin SH. Update on fetal hemoglobin gene regulation in hemoglobinopathies. CurrOpinPediatr. 2011; 23(1):1-8.
27-Daniel EB, Stuart HO. Update on fetal hemoglobin gene regulation in hemoglobinopathies. Curr Opin Pediatr. 2011; 23(1): 1–8.
28-Martin H. Steinberg, Paola Sebastiani.Genetic Modifiers of Sickle Cell Disease. Am J Hematol. 2012; 87(8): 795–803.
29-Cox SE, Makani J, Newton CR, Kirkham FJ. Hematological and genetic predictors of daytime hemoglobin saturation in Tanzanian children with and without sickkle cell anemia. Interanational Scholarlary Research Network Hematology. 2013; 1–6.
30- Tarer V, Etienne-Julan M, Diara JP, Belloy MS, Mukizi-Mukaza M, Elion J, et al. Sickle cell anemia in Guadeloupean children: pattern and prevalenc of acute clinical events. European Journal of Hematology. 2006; 193–199.
31- Belisário AR, Rodrigues CV, Martins ML, Silva CM & Viana MB. Coinheritance of α -thalassemia decreases the risk of cerebrovascular disease in a cohort of children with sickle cell anemia. Hemoglobin. 2010; 34: 516–529
32- Pandey S, Pandey Sw, Mishra RM, Sharma M. Genotypic influence of a-deletions on the phenotype of Indian sickle cell anemia patients. Korean Journal of Hematology. 2011; 46: 192–195.
33- Alsultan A, Aleem A, Ghabbour H, AlGahtani FH, Al-Shehri A, et al. Sickle cell disease subphenotypes in patients from South Western province of Saudi-Arabia. Journal of Pediatric Hematology Oncology. 2012; 34: 79–84.
34- Bernaudin F, Verlhac S, Chevret S, Torres M, Coic L, Arnaud C, et al. G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood. 2008; 112: 4314–4317.
35-Rumaney MB, Ngo Bitoungui VJ, Vorster AA, Ramesar R, Kengne AP, Ngogang J, et al. The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival. PLoS One. 2014; 9(6):e100516.
36-Makani J, Menzel S, Nkya S, Cox SE, Drasar E, Soka D, et al. Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia. Blood. 2011; 117(4):1390-1392
37-Green NS, Barral S. Emerging science of hydroxyurea therapy for pediatric sickle cell disease. Pediatr Res. 2014;75(1‑2):196‑204.
38- Friedrisch JR, Sheehan V, Flanagan JM, et al. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil. Blood Cells Mol Dis. 2016; 62:32‑37.
39- Creary LE, Ulug P, Menzel S, McKenzie CA, Hanchard NA, Taylor V, et al variation on chromosome 6 influences F cell levels in healthy individuals of African descent and HbF levels in sickle cell
patients. PLoS One. 2009;4(1):e4218.
40-Wonkam A, Ngo Bitoungui VJ, Vorster AA, Ramesar R, Cooper RS, Tayo B et al. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon. PloS One. 2014; 9(3):e92506.
41-Farrell JJ, Sherva RM, Chen Z-Y, Luo HY, Chu BF, Ha SY, et al. A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood. 2011; 117(18):4935‑45.
42-Stadhouders R, Aktuna S, Thongjuea S, Aghajanirefah A, Pourfarzad F, van Ijcken W, et al. HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers. J Clin Invest. 2014;124(4):1699-1710.
43- Lettre G, Sankaran VG, Bezerra MA, Araújo AS, Uda M, Sanna S, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc NatlAcadSci U S A. 2008;105(33):11869-11874.
44- Danjou F, Francavilla M, Anni F, Satta S, Demartis FR, Perseu L, et al. A genetic score for the prediction of beta-thalassemia severity.Haematologica. 2015;100(4):452-457.
45-Galarneau G, Palmer CD, Sankaran VG, Orkin SH, Hirschhorn JN, Lettre G, et al. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet. 2010; 42(12):1049-1955.
46-Steinberg MH. Genetic etiologies for phenotypic diversity in sickle cell anemia.Scientific World Journal. 2009;9:46-67.
47-Joly P, Pondarré C, Bardel C, Francina A, Martin C. The alpha-globin genotype does not influence sickle cell disease severity in a retrospective cross-validation study of the pediatric severity score. Eur J Haematol. 2012; 88(1):61-67.